Haemonetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.About HAE
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.
HAE Key Statistics
Stock Snapshot
As of today, Haemonetics(HAE) shares are valued at $70.76. The company's market cap stands at 3.41B, with a P/E ratio of 20.48.
On 2025-11-07, Haemonetics(HAE) stock traded between a low of $66.82 and a high of $70.99. Shares are currently priced at $70.76, which is +5.9% above the low and -0.3% below the high.
Haemonetics(HAE) shares are trading with a volume of 148.48K, against a daily average of 896K.
In the last year, Haemonetics(HAE) shares hit a 52-week high of $94.99 and a 52-week low of $47.32.
In the last year, Haemonetics(HAE) shares hit a 52-week high of $94.99 and a 52-week low of $47.32.
HAE News
BofA upgraded Haemonetics (HAE) to Neutral from Underperform with a price target of $75, up from $58. Plasma volume growth returned to high single digits in the...
Haemonetics Corporation ( ) shares have had a really impressive month, gaining 36% after a shaky period beforehand. Unfortunately, the gains of the last month d...
Earnings Call Insights Haemonetics raises 2026 guidance, projects 7%–10% organic growth ex CSL amid strong plasma and hospital performance Nov. 07, 2025 3:27 AM...
Analyst ratings
82%
of 11 ratingsMore HAE News
(RTTNews) - Haemonetics Corp (HAE) revealed a profit for its second quarter that Increases, from last year The company's bottom line came in at $38.68 million,...
Needham analyst Michael Matson maintained a Buy rating on Haemonetics today and set a price target of $78.00. Meet Your ETF AI Analyst Discover how TipRanks' ET...